WCA
AGN

Westover Capital Advisors’s Allergan plc AGN Stock Holding History

Westover Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,982
Closed -$979K – 126
2017
Q4 		$979K Buy
5,982
+449
+8% +$80.6K 0.54% 60
2017
Q3 		$1.13M Buy
5,533
+1,090
+25% +$253K 0.67% 46
2017
Q2 		$1.08M Sell
4,443
-101
-2% -$23.7K 0.71% 48
2017
Q1 		$1.09M Buy
+4,544
New +$1.06M 0.72% 45

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Westover Capital Advisors's AGN Position: Q1 2018 in Review

Westover Capital Advisors sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 5,982 shares — an estimated $979K sold.

Westover Capital Advisors first reported a position in AGN in Q1 2017 and held it in 4 quarters. The position peaked at $1.13M in Q3 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Westover Capital Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Westover Capital Advisors sold 5,982 Allergan plc shares in Q1 2018, an estimated $979K.
  • Westover Capital Advisors first reported a position in Allergan plc in Q1 2017 and held it in 4 quarters.
  • Westover Capital Advisors's Allergan plc position peaked at $1.13M in Q3 2017.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Westover Capital Advisors's 13F filing for Q1 2018, filed 11 May 2018.